Skip to main content Accessibility help
  • Print publication year: 2009
  • Online publication date: June 2012

8 - Prevention of infectious disease

Related content

Powered by UNSILO
Stern, AM, Markel, H. The history of vaccines and immunization: familiar patterns, new challenges. Health Affairs (Project Hope). 2005 May–Jun; 24(3): 611–21.
,WHO. Mortality: Revised Global Burden of Disease (2002) Estimates. Geneva: World Health Organization; 2002.
Kasper, DL, Braunwald, E, Fauci, AS, Hauser, SL, Longo, DL, Jameson, JL, eds. Harrison's Principles of Internal Medicine. 16th edn. New York: McGraw-Hill; 2005.
Sompayrac, L. How Pathogenic Viruses Work. Sudbury, MA: Jones and Bartlett Publishers 2002.
,Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 10th edn. Washington DC: Public Health Foundation; 2007.
Sompayrac, L. How the Immune System Works. 2nd edn. Boulder Blackwell Publishing; 2003.
Silverthorn, DU. Human Physiology : an Integrated Approach. 3rd edn. San Francisco: Pearson/Benjamin Cummings; 2004.
,Centers for Disease Control and Prevention. 2004–05 U.S. Influenza Season Summary. Atlanta, GA; 2005 July 5.
,WHO Regional Office for the Eastern Mediterranean. Avian Influenza (Bird Flu): an Introduction. Division of Communicable Disease Control Newsletter. 2005 November (7).
Tumpey, TM, Basler, CF, Aguilar, PV, Zeng, H, Solorzano, A, Swayne, , et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science (New York, NY). 2005 Oct 7; 310(5745): 77–80.
Kobasa, D, Jones, SM, Shinya, K, Kash, JC, Copps, J, Ebihara, H, et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature. 2007 Jan 18; 445(7125): 319–23.
Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO. 2007 April 11 [cited 2007 April 23]; Available from:
,World Health Organization. Avian Influenza Frequently Asked Questions. 2005 December 5 [cited 2007 April 23]; Available from:
Ulmer, JB, Valley, U, Rappuoli, R. Vaccine manufacturing: challenges and solutions. Nature Biotechnology. 2006 Nov; 24(11): 1377–83.
Matthews, JT. Egg-based production of influenza vaccine: 30 years of commerical experience. The Bridge. 2006; 36(3): 17–24.
Langridge, WHR. Edible vaccines. Scientific American. 2000; 283(3): 66–71.
Bloom, BR, Lambert, PH, eds. The Vaccine Book. San Diego: Academic Press; 2003.
Fenner, F, Henderson, DA, Arita, I, Jezek, Z, Ladnyi, ID. Smallpox and its Eradication. Geneva: World Health Organization; 1988.
Smith, KA. Medical immunology: a new journal for a new subspecialty. Medical Immunology. 2002 Sep 30; 1(1): 1.
Abbas, AK, Lichtman, AH. Basic Immunology: Functions and Disorders of the Immune System. 2nd edn. Philadelphia: W.B. Saunders; 2004.
Mahmoud, A. The vaccine enterprise: time to act. Health Affairs. 2005; 24(3): 596–7.
The infrastructure for vaccine development. Health Affairs. 2005; 24(3): 598.
Levine, R. Millions Saved: Proven Successes in Global Health. Washington D.C.: Center for Global Development; 2004.
,Unicef. Immunization Summary 2006. New York: Unicef and WHO; 2006 January.
,Nurse Takes Plunge in Ebola Test. All Things Considered: National Public Radio; 2003.
Orenstein, WA, Douglas, RG, Rodewald, , Hinman, AR. Immunizations in the United States: success, structure, and stress. Health Affairs (Project Hope). 2005 May–Jun; 24(3): 599–610.
,Vaccine Education Center – Children's Hospital of Philadelphia. Frequently Asked Questions. 2003 [cited 2007 April 25]; Available from:
,National Network for Immunization Information. Why Immunize? How Childhood Vaccines are Selected for Routine Use. 2004 [cited 2007 April 25]; Available from:
,National Network for Immunization Information. Why Immunize? Monitoring Vaccine Safety. 2007 [cited 2007 April 25]; Available from:
,National Network for Immunization Information. Why Immunize? How Vaccines Work. 2007 [cited 2007 April 25]; Available from:
,Centers for Disease Control and Prevention. Diptheria epidemic – new independent states of the former Soviet Union, 1990–1994. Morbidity and Mortality Weekly Report. 1995; 44(10).
Colgrove, J, Bayer, R. Could it happen here? Vaccine risk controversies and the specter of derailment. Health Affairs (Project Hope). 2005 May–Jun; 24(3): 729–39.
Offit, PA. Why are pharmaceutical companies gradually abandoning vaccines?Health Affairs (Project Hope). 2005 May–Jun; 24(3): 622–30.
Wakefield, AJ, Murch, SH, Anthony, A, Linnell, J, Casson, DM, Malik, M, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. The Lancet. 1998 Feb 28; 351(9103): 637–41.
,Centers for Disease Control and Prevention. Childhood & Adolescent Immunization Schedules 2007 [cited 2007 April 27]; Available from:
Buckland, BC. The process development challenge for a new vaccine. Nature Medicine. 2005 Apr; 11(4 Suppl.): S16–19.
Smith, NM, Bresee, JS, Shay, DK, Uyeki, TM, Cox, NJ, Strikas, RA. Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report. 2006 July 28; 55(RR-10).
Scannon, PJ. Pharmaceutical preparedness for an epidemic. The Bridge. 2006; 36(3): 10–16.
,Centers for Disease Control and Prevention. Vaccine Storage and Handling Toolkit. 2005 June [cited 2007 April 30]; Available from:
Estell, D. Adapting industry practices for the rapid, large scale manufacture of pharmaceutical proteins. The Bridge. 2006; 36(3): 39–44.
Rappuoli, R. Cell culture based vaccine production: technological options. The Bridge. 2006; 36(3): 25–30.
Shaw, A. Alternative methods of making influenza vaccines. The Bridge. 2006; 36(3): 31–8.
Anderson, RM. Planning for pandemics of infectious diseases. The Bridge. 2006; 36(3): 5–9.
Clancy, C, Callaghan, M, Kelly, T. A multi-scale problem arising in a model of avian flu virus in a seabird colony. Journal of Physics: Conference Series. 2006; 55: 45–54.
Heuer, AH. Engineering and vaccine production for an influenza pandemic. The Bridge. 2006; 36(3): 3–4.
,Institute of Medicine. Financing Vaccines in the 21st Century: Assuring Access and Availability. Washington D.C.: National Academies Press; 2003.
McCluskey, MM, Alexander, SB, Larkin, BD, Murguia, M, Wakefield, S. An HIV vaccine: as we build it, will they come?Health Affairs (Project Hope). 2005 May–Jun; 24(3): 643–51.
Vaccine Vial Monitors (VVMs). Seattle: PATH; 2005.
Safe Vaccine Handling, Cold Chain and Immunizations. Geneva: World Health Organization; 1998.
HealthTech Historical Profile: Technologies for Injection Safety. Seattle: PATH; 2006 January.
BD Immunization. 2007 [cited 2007 May 1]; Available from:
Levine, MM. Can needle-free administration of vaccines become the norm in global immunization? Nature Medicine. 2003 Jan; 9(1): 99–103.
GAVI Alliance Progress Report. 2007; Available from:
Beal, J, Orrick, J, Alfonso, K, Rathore, M, eds. HIV/AIDS Primary Care Guide: Florida/Caribbean AIDS Education Training Center; 2006.
,Centers for Disease Control and Prevention. Frequently Asked Questions About HIV and HIV Testing [cited 2007 May 3]; Available from:
Chou, R, Huffman, LH, Fu, R, Smits, AK, Korthuis, PT. Screening for HIV: a review of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 2005 Jul 5; 143(1): 55–73.
Smith, KA. The HIV vaccine saga. Medical Immunology. 2003 Feb 14; 2(1): 1.
Baltimore, D, Heilman, C. HIV vaccines: prospects and challenges. Scientific American. 1998 July; 279(1): 98–103.
Letvin, NL. Progress and obstacles in the development of an AIDS vaccine. Nature Reviews. 2006 Dec; 6(12): 930–9.
Nowak, MA, McMichael, AJ. How HIV defeats the immune system. HIV: 20 Years of Research: Scientific American; 2003.
Carmichael, M. How it began: HIV before the age of AIDS. PBS Frontline. 2006 May 30.
Ezzel, C. Hope in a Vial. HIV: 20 Years of Research: Scientific American 2003: 38–43.
Singh, M. No vaccine against HIV yet – are we not perfectly equipped?Virology Journal. 2006; 3: 60.
Eaton, L. AIDS vaccine may offer hope only for some ethnic groups. BMJ (Clinical research edn. 2003 Mar 1; 326(7387): 463.
,AIDS vaccine only limited success. BBC News. 2003 February 24.
Kresge, KJ. VRC starts Phase II vaccine trial. VAX. 2005 October; 3(+++++10).